Track Myriad Genetics's inventory ($31M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), MYGN shows a inventory of $31M. That compares with $29M in the prior-year period — up 6.6% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MYGN's inventory is now $31M (was $29M) — a 6.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Myriad Genetics is outperforming or lagging.
Tracking MYGN's inventory over time shows whether Myriad Genetics is scaling, shrinking, or reshaping that part of the business. The current reading is $31M That compares with $29M in the prior-year period — up 6.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this inventory page, Stockcircle has Myriad Genetics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $31M) with ownership activity and broader fundamentals.
Myriad Genetics's inventory is $31M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.